BioSpace News Archive

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced that it will participate in the Jefferies Virtual Healthcare Conference, June 2-4, 2020.

Enzo Biochem, Inc. a leading biosciences and diagnostics company, announced the recent issuance of U.S. Patent No. 10,626,170 entitled Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor.

IntelGenx Technologies Corp. announced that it is proposing to amend the terms of its 8.0% convertible unsecured subordinated debentures due June 30, 2020, originally issued on July 12, 2017 and August 8, 2017, to extend the maturity date from June 30, 2020 to June 30, 2022 and reduce the conversion price from $1.35 to $0.50.

Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced two poster presentations at the virtual 23rd Annual Meeting of the American Society of Gene & Cell Therapy (“ASGCT”), being held May 12-15, 2020. Manuel Litchman, M.D., P

Otonomy, Inc. announced preclinical results from the company’s gene therapy collaboration with Applied Genetic Technologies Corporation that support the selection of a product candidate for development as a treatment for gap junction beta-2 deficiency, the most common cause of congenital hearing loss.

Ovid Therapeutics Inc. announced that Amit Rakhit, M.D., MBA, President and Chief Medical Officer, will participate in a fireside chat at the 2020 RBC Capital Markets Virtual Global Healthcare Conference on Tuesday, May 19, at 1:20 p.m. ET.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that the Company has issued its May 2020 Shareholder Letter.

Company to Hold GAIN Live Webinar with DREAM Investigator Tomorrow, May 13, at 7 p.m.

Key Biologics and Astarte Biologics, together the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced its rebranding to Cellero.

INOVIO (NASDAQ:INO) today announced that Dr. J. Joseph Kim , President and CEO, along with other members of management will present in a fireside discussion at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2020 at 2:30 p.m. Eastern Time . This fireside discussion will be held virtually and a live w